Case Report of Intrahepatic Cholestasis Associated with ATP8B1 Gene Mutation in a Patient with Human Immunodeficiency Virus (HIV) Infection: A Diagnostic Challenge

Authors

DOI:

https://doi.org/10.22516/25007440.1120

Keywords:

Jaundice, Intrahepatic cholestasis, Mutation

Abstract

Benign recurrent intrahepatic cholestasis (BRIC) is a rare condition that is part of a spectrum of disorders known as familial intrahepatic cholestasis. It is characterized by episodes of cholestasis lasting weeks to months with complete resolution between episodes. BRIC is associated with a good prognosis compared to other conditions, due to its later onset and lower association with fibrosis. Diagnosis is one of exclusion, posing a diagnostic challenge that requires a high index of suspicion and is confirmed by identifying the ATP8B1 gene mutation.

This report presents the case of a patient with human immunodeficiency virus (HIV) who developed severe intrahepatic cholestasis and had a history of recurrent jaundice throughout his life. After extensive studies of intrahepatic cholestasis, he was diagnosed with symptomatic BRIC with the ATP8B1 gene mutation.

Downloads

Download data is not yet available.

Author Biographies

Darwin Jhoan Ariza Rodriguez, Hospital Universitario San Ignacio

Specialist in Internal Medicine, Internist, Hospital Universitario San Ignacio. Bogotá, Colombia.

Valentina Davila Ruales, Hospital Universitario San Ignacio

Specialist in Internal Medicine, Internist, Hospital Universitario San Ignacio. Bogotá, Colombia.

Carmen Yanette Suarez Quintero, Hospital Universitario San Ignacio

Specialist in Internal Medicine, Gastroenterology, and Clinical Hepatology. Gastroenterologist, Hospital Universitario San Ignacio. Bogotá, Colombia.

Sandra Amado Garzón, Hospital Universitario San Ignacio

Specialist in Internal Medicine, Internist, Hospital Universitario San Ignacio. Bogotá, Colombia.

References

Halawi A, Ibrahim N, Bitar R. Triggers of benign recurrent intrahepatic cholestasis and its pathophysiology: a review of literature. Acta Gastroenterol Belg. 2021;84(3):477-86. https://doi.org/10.51821/84.3.013

van der Woerd WL, van Mil SWC, Stapelbroek JM, Klomp LWJ, van de Graaf SFJ, Houwen RHJ. Familial cholestasis: Progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol. 2010;24(5):541-53. https://doi.org/10.1016/j.bpg.2010.07.010

Gunaydin M, Bozkurter Cil AT. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment. Hepat Med. 2018;10:95-104. https://doi.org/10.2147/HMER.S137209

Felzen A, Verkade HJ. The spectrum of Progressive Familial Intrahepatic Cholestasis diseases: Update on pathophysiology and emerging treatments. Eur J Med Genet. 2021;64(11):104317. https://doi.org/10.1016/j.ejmg.2021.104317

van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Shneider BL, Sokal E, et al. Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency. Hepatology. 2021;74(2):892-906. https://doi.org/10.1002/hep.31787

Folvik G, Hilde O, Helge GO. Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases. Scand J Gastroenterol. 2012;47(4):482-8. https://doi.org/10.3109/00365521.2011.650191

De Vloo C, Nevens F. Cholestatic pruritus: an update. Acta Gastroenterol Belg. 2019;82(1):75-82.

Van Berge Henegouwen GP. Benign recurrent intrahepatic cholestasis and Byler’s disease: one gene, two diseases? J Hepatol. 1996;25(3):395-7. https://doi.org/10.1016/S0168-8278(96)80128-0

van Ooteghem NAM, Klomp LWJ, van Berge-Henegouwen GP, Houwen RHJ. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum. J Hepatol. 2002;36(3):439-43. https://doi.org/10.1016/S0168-8278(01)00299-9

van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 Disease: A Spectrum of Intrahepatic Cholestatic Disorders. Semin Liver Dis. 2001;21(04):535-44. https://doi.org/10.1055/s-2001-19034

Amirneni S, Haep N, Gad MA, Soto-Gutierrez A, Squires JE, Florentino RM. Molecular overview of progressive familial intrahepatic cholestasis. World J Gastroenterol. 2020;26(47):7470-84. https://doi.org/10.3748/wjg.v26.i47.7470

Andersen JP, Vestergaard AL, Mikkelsen SA, Mogensen LS, Chalat M, Molday RS. P4-ATPases as Phospholipid Flippases-Structure, Function, and Enigmas. Front Physiol. 2016;7:275. https://doi.org/10.3389/fphys.2016.00275

Luketic VA, Shiffman ML. Benign recurrent intrahepatic cholestasis. Clin Liver Dis. 2004;8(1):133-149. https://doi.org/10.1016/S1089-3261(03)00133-8

Crosigani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KDR. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: A study of bile acid metabolism. Hepatology. 1991;13(6):1076-83. https://doi.org/10.1002/hep.1840130612

Figure 1. Bilirubin levels over time. Author’s own research.

Published

2024-09-30

How to Cite

Ariza Rodriguez, D. J., Davila Ruales, V., Suarez Quintero, C. Y., & Amado Garzón, S. (2024). Case Report of Intrahepatic Cholestasis Associated with ATP8B1 Gene Mutation in a Patient with Human Immunodeficiency Virus (HIV) Infection: A Diagnostic Challenge. Revista Colombiana De Gastroenterología, 39(3), 323–327. https://doi.org/10.22516/25007440.1120

Altmetric

Crossref Cited-by logo
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code